Sheridan Capital Partners has appointed Pritesh Patel as Director of Digital and AI Transformation. Roo Partners advised on the search.
Sheridan Capital Partners is a healthcare-focused private equity firm that takes a thematic, hands-on approach to partnering with middle-market healthcare businesses, combining capital markets sophistication with operational resources to accelerate growth. The firm’s model depends on bringing capability to its portfolio companies rather than expecting each one to build it independently.
Patel brings extensive experience developing scalable AI-powered solutions and leading enterprise-wide digital transformation in healthcare. His work has centered on connecting advanced technology to business objectives rather than treating the two as separate tracks, which is a distinction that matters more in healthcare than in most sectors. Regulatory constraints, fragmented data environments, and clinical workflow realities mean that technology which works in theory frequently fails in deployment.
The role itself is notable. Sponsors are increasingly building digital and AI capability at the firm level rather than leaving it to individual portfolio companies to solve on their own. That shifts what the mandate requires. A firm-level technology leader has to operate across businesses at different stages of maturity, with different systems, different clinical or operational contexts, and different appetites for change. The work is as much about assessing where capability can realistically be built as it is about building it.
For healthcare-focused sponsors specifically, the stakes are compounding. AI adoption is moving faster than most middle-market healthcare businesses can absorb it, and the gap between what the technology enables and what an organization can actually implement is widening. Sponsors who close that gap early will hold a meaningful advantage over a hold period.
Roo Partners is a retained executive search firm for private equity and growth equity-backed companies, engaged when leadership decisions are complex and central to the investment thesis. The firm works across healthcare, life sciences, technology, manufacturing, and business services, with offices in Coconut Grove, Florida and New York City.